"30 Blood-based glycoprotein signatures in advanced non-small-cell lung carcinoma (NSCLC) receiving first-line immune checkpoint blockade"
— BMJ Publishing Group Ltd
"Differential Glycoprotein Profiles in Severe and Asymptomatic COVID-19"
— American Society for Mass Spectrometry, 2021
"Glycoproteomics as a Powerful Liquid Biopsy-based Predictor of Checkpoint-inhibitor Treatment Response"
— American Association for Cancer Research
"Serum glycoproteomic-based liquid biopsy for the detection of pancreatic ductal adenocarcinoma."
— Journal of Clinical Oncology